BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 33823894)

  • 1. Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling.
    Yang Q; Zhao S; Shi Z; Cao L; Liu J; Pan T; Zhou D; Zhang J
    J Exp Clin Cancer Res; 2021 Apr; 40(1):120. PubMed ID: 33823894
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy-induced exosomal circBACH1 promotes breast cancer resistance and stemness via miR-217/G3BP2 signaling pathway.
    Xia W; Chen W; Ni C; Meng X; Wu J; Yang Q; Tang H; Yuan H; Fang S
    Breast Cancer Res; 2023 Jul; 25(1):85. PubMed ID: 37461019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exosomal release of microRNA-454 by breast cancer cells sustains biological properties of cancer stem cells via the PRRT2/Wnt axis in ovarian cancer.
    Wang L; He M; Fu L; Jin Y
    Life Sci; 2020 Sep; 257():118024. PubMed ID: 32598931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exosomes secreted by M2 macrophages promote cancer stemness of hepatocellular carcinoma via the miR-27a-3p/TXNIP pathways.
    Li W; Xin X; Li X; Geng J; Sun Y
    Int Immunopharmacol; 2021 Dec; 101(Pt A):107585. PubMed ID: 34601333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
    Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
    Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
    [No Abstract]   [Full Text] [Related]  

  • 6. Cancer-associated fibroblast-derived exosomal microRNA-24-3p enhances colon cancer cell resistance to MTX by down-regulating CDX2/HEPH axis.
    Zhang HW; Shi Y; Liu JB; Wang HM; Wang PY; Wu ZJ; Li L; Gu LP; Cao PS; Wang GR; Ma YS; Fu D
    J Cell Mol Med; 2021 Apr; 25(8):3699-3713. PubMed ID: 33621425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exosomes Mediated Transfer of Circ_UBE2D2 Enhances the Resistance of Breast Cancer to Tamoxifen by Binding to MiR-200a-3p.
    Hu K; Liu X; Li Y; Li Q; Xu Y; Zeng W; Zhong G; Yu C
    Med Sci Monit; 2020 Aug; 26():e922253. PubMed ID: 32756532
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exosome-Mediated Transfer of circ_0000338 Enhances 5-Fluorouracil Resistance in Colorectal Cancer through Regulating MicroRNA 217 (miR-217) and miR-485-3p.
    Zhao K; Cheng X; Ye Z; Li Y; Peng W; Wu Y; Xing C
    Mol Cell Biol; 2021 Apr; 41(5):. PubMed ID: 33722958
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exosomal circPACRGL promotes progression of colorectal cancer via the miR-142-3p/miR-506-3p- TGF-β1 axis.
    Shang A; Gu C; Wang W; Wang X; Sun J; Zeng B; Chen C; Chang W; Ping Y; Ji P; Wu J; Quan W; Yao Y; Zhou Y; Sun Z; Li D
    Mol Cancer; 2020 Jul; 19(1):117. PubMed ID: 32713345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miRNA-221-3p derived from M2-polarized tumor-associated macrophage exosomes aggravates the growth and metastasis of osteosarcoma through SOCS3/JAK2/STAT3 axis.
    Liu W; Long Q; Zhang W; Zeng D; Hu B; Liu S; Chen L
    Aging (Albany NY); 2021 Aug; 13(15):19760-19775. PubMed ID: 34388111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes loaded with circPARD3 promotes EBV-miR-BART4-induced stemness and cisplatin resistance in nasopharyngeal carcinoma side population cells through the miR-579-3p/SIRT1/SSRP1 axis.
    Ai J; Tan G; Li W; Liu H; Li T; Zhang G; Zhou Z; Gan Y
    Cell Biol Toxicol; 2023 Apr; 39(2):537-556. PubMed ID: 35844005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exosomal lncRNA H19 promotes the progression of hepatocellular carcinoma treated with Propofol via miR-520a-3p/LIMK1 axis.
    Wang D; Xing N; Yang T; Liu J; Zhao H; He J; Ai Y; Yang J
    Cancer Med; 2020 Oct; 9(19):7218-7230. PubMed ID: 32767662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling.
    Zhao Q; Liu Y; Wang T; Yang Y; Ni H; Liu H; Guo Q; Xi T; Zheng L
    Eur J Pharmacol; 2020 Oct; 884():173359. PubMed ID: 32738343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal MiR-500a-3p promotes cisplatin resistance and stemness via negatively regulating FBXW7 in gastric cancer.
    Lin H; Zhang L; Zhang C; Liu P
    J Cell Mol Med; 2020 Aug; 24(16):8930-8941. PubMed ID: 32588541
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STAT3-induced HLA-F-AS1 promotes cell proliferation and stemness characteristics in triple negative breast cancer cells by upregulating TRABD.
    Wu D; Jia H; Zhang Z; Li S
    Bioorg Chem; 2021 Apr; 109():104722. PubMed ID: 33618253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exosomal miR-361-3p promotes the viability of breast cancer cells by targeting ETV7 and BATF2 to upregulate the PAI-1/ERK pathway.
    Li Y; Fan L; Yan A; Ren X; Zhao Y; Hua B
    J Transl Med; 2024 Jan; 22(1):112. PubMed ID: 38282047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. siRNA treatment targeting integrin α11 overexpressed via EZH2-driven axis inhibits drug-resistant breast cancer progression.
    Chaudhary P; Yadav K; Lee HJ; Kang KW; Mo J; Kim JA
    Breast Cancer Res; 2024 Apr; 26(1):72. PubMed ID: 38664825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EZH2-mediated Epigenetic Silencing of miR-29/miR-30 targets LOXL4 and contributes to Tumorigenesis, Metastasis, and Immune Microenvironment Remodeling in Breast Cancer.
    Yin H; Wang Y; Wu Y; Zhang X; Zhang X; Liu J; Wang T; Fan J; Sun J; Yang A; Zhang R
    Theranostics; 2020; 10(19):8494-8512. PubMed ID: 32754259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-378a-3p acts as a tumor suppressor in gastric cancer
    Xu X; Li Y; Liu G; Li K; Chen P; Gao Y; Liang W; Xi H; Wang X; Wei B; Li H; Chen L
    Cancer Biol Med; 2022 Oct; 19(12):1662-82. PubMed ID: 36245214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exosomal miRNA-205 promotes breast cancer chemoresistance and tumorigenesis through E2F1.
    Zhao Y; Jin LJ; Zhang XY
    Aging (Albany NY); 2021 Jul; 13(14):18498-18514. PubMed ID: 34292880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.